Pfizer reports new Covid-19 vaccine data from open-label studynews2025-09-08T18:13:38+00:00September 8th, 2025|Endpoints News|
Eli Lilly’s Jaypirca shows ‘striking’ results in first-line lymphoma patients news2025-09-08T17:22:51+00:00September 8th, 2025|Endpoints News|
#WCLC25: BioNTech, Bristol Myers tout PD-L1xVEGF results in small cell lung cancernews2025-09-08T15:00:45+00:00September 8th, 2025|Endpoints News|
#WCLC25: AstraZeneca’s Tagrisso combo extends survival by 10 months in EGFR-mutant lung cancernews2025-09-08T08:22:44+00:00September 8th, 2025|Endpoints News|
#WorldSleep2025: Takeda’s Phase 3 narcolepsy results could make it first mover in multibillion-dollar marketnews2025-09-08T07:15:19+00:00September 8th, 2025|Endpoints News|
Servier buys Medicxi startup’s fragile X candidate for up to $450Mnews2025-09-08T06:30:05+00:00September 8th, 2025|Endpoints News|
#WCLC25: Merck and Daiichi Sankyo head to FDA with ADC for small cell lung cancernews2025-09-07T21:31:10+00:00September 7th, 2025|Endpoints News|
FDA is readying more surprise inspections for foreign drug sites, Makary saysnews2025-09-05T17:36:12+00:00September 5th, 2025|Endpoints News|
Japan-made generic drugs will be exempt from Trump’s reciprocal tariff news2025-09-05T13:34:38+00:00September 5th, 2025|Endpoints News|
WHO adds GLP-1s to essential medicines listnews2025-09-05T13:00:18+00:00September 5th, 2025|Endpoints News|
